A Phase IIb Randomized, Placebo-controlled, Double-blind Trial of Azithromycin to Eradicate Ureaplasma Respiratory Tract Infection in Preterm Infants
Latest Information Update: 22 Jul 2022
At a glance
- Drugs Azithromycin (Primary)
- Indications Bacterial infections; Respiratory tract infections; Ureaplasma infections
- Focus Therapeutic Use
- Acronyms AZIPIII
- 03 Nov 2020 Status changed from active, no longer recruiting to completed.
- 01 Nov 2020 Results published in the Archives of Disease in Childhood. Fetal and Neonatal Edition
- 23 Mar 2020 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.